Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of GERD
NCT ID: NCT00524355
Last Updated: 2009-07-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2717 participants
OBSERVATIONAL
2007-03-31
2007-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment.
NCT00786773
Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Track (GIT) Symptoms in Thailand
NCT00999063
Symptoms and Management Strategies in Gastroesophageal Reflux Disease (GERD)
NCT00768443
Impact of GERD on Daily Life (NIS)
NCT00545883
An Epidemiological Study to Describe Symptom Control and Impact of Gastroesophageal Reflux Disease
NCT01134367
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients complaining of symptoms consistent with reflux disease
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ta Long, MD, PhD
Role: STUDY_CHAIR
108 Hospital, Hanoi
Do Van Dung, MD, PhD
Role: STUDY_CHAIR
Ho Chi Minh City Univ of Medicine and Pharmacist
Dao Van Long, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Ha Noi University of Medicine Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Hanoi, , Vietnam
Research Site
Ho Chi Minh City, , Vietnam
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-G84-GER-2007/2
Identifier Type: -
Identifier Source: secondary_id
NIS-GVN-NEX-2007/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.